CBX4 Drives Gastric Cancer Progression by Activating <b>β</b>-Catenin Signaling

CBX4 upregulation promotes GC progression via β-catenin signaling activation. The CBX4/β-catenin axis emerges as a promising therapeutic target, offering potential for the development of precision treatment strategies in GC management.

Institutions

Publication Details

Journal
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Published
2025-09-24
DOI
https://doi.org/10.32604/or.2025.068651
Primary Topic
Library Science and Administration
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Library Science and Administration
article

CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling

article en

Abstract

CBX4 upregulation promotes GC progression via β-catenin signaling activation. The CBX4/β-catenin axis emerges as a promising therapeutic target, offering potential for the development of precision treatment strategies in GC management.

Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsVol. 34(1)
Soochow University (CN), First Affiliated Hospital of Soochow University (CN)
Good health and well-being
Openalex Percentile: Top 53%
Library Science and Administration
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CBX4 Drives Gastric Cancer Progression by Activating <b>β</b>-Catenin Signaling · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2025) | TGRS Research Map | TGRS